MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3349/ymj.2013.54.5.1234

Медицинская библиотека · Yonsei medical journal · 2013

Posaconazole treatment in Korea: single-center experience over 5 years.

Lee Hyo-Jin, Kwon Jae-Cheol, Kim Si-Hyun, Choi Su-Mi, Lee Dong-Gun, Park Sun-Hee, Choi Jung-Hyun, Yoo Jin-Hong, Cho Byung-Sik, Lee Seok, Kim Hee-Je, Min Chang-Ki, Lee Jong-Wook, Min Woo-Sung

Клинический случайСтатьяПеревод в очереди

Аннотация

PURPOSE: Posaconazole is a second-generation triazole with a broad spectrum. However, there is a lack of data to support a significant role for posaconazole in the treatment of invasive fungal infection (IFI), especially in Korea. Until recently, posaconazole was available only through the Korean Orphan Drug Center. This study was designed to review the use of posaconazole at a single-center in Korea.

MATERIALS AND

METHODS

Data from patients who received posaconazole treatment at Catholic Blood and Marrow Transplantation Center were retrospectively reviewed between January 2007 and September 2012.

RESULTS

A total of 11 cases (3 males and 8 females, median age 52 years) received posaconazole. Five patients were given the drug for mucormycosis, two for invasive aspergillosis, and four for unspecified IFI for which galactomannan (GM) assays were negative. The treatment duration ranged from 4-250 days. Three patients received posaconazole for management refractory IFI, two for intolerance of previous antifungal therapy, and six for long-term maintenance treatment. The overall successful response rate to posaconazole was 55% (six of eleven patients). Five of eleven patients died during the study period. However, only one death was attributed to the progression of IFI. None of the patients discontinued posaconazole therapy due to adverse events.

CONCLUSION

Posaconazole is an attractive oral antifungal agent for salvage treatment of IFI, particularly upon diagnosis of mucormycosis or in cases in which mucormycosis cannot be ruled out due to a negative GM.

Для цитирования: Lee Hyo-Jin, Kwon Jae-Cheol, Kim Si-Hyun, Choi Su-Mi, Lee Dong-Gun, Park Sun-Hee, Choi Jung-Hyun, Yoo Jin-Hong, Cho Byung-Sik, Lee Seok, Kim Hee-Je, Min Chang-Ki, Lee Jong-Wook, Min Woo-Sung. Posaconazole treatment in Korea: single-center experience over 5 years.. Yonsei medical journal. 2013. DOI: 10.3349/ymj.2013.54.5.1234.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.